These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 6097166)

  • 1. Pharmacokinetics of cefotiam administered intravenously and intramuscularly to healthy adults.
    Brisson AM; Bryskier A; Millerioux L; Fourtillan JB
    Antimicrob Agents Chemother; 1984 Oct; 26(4):513-8. PubMed ID: 6097166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of cefotiam in humans.
    Rouan MC; Lecaillon JB; Guibert J; Modai J; Schoeller JP
    Antimicrob Agents Chemother; 1985 Feb; 27(2):177-80. PubMed ID: 3857018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic study of cefmenoxime (SCE 1365-CMX) in healthy adults.
    Fourtillan JB; Bryskier A; Mignot A; Borsa F; Humbert G
    Am J Med; 1984 Dec; 77(6A):28-31. PubMed ID: 6097120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of cefmetazole administered intramuscularly and intravenously to healthy adults.
    Rodriguez-Barbero J; Mariño EL; Dominguez-Gil A
    Antimicrob Agents Chemother; 1985 Oct; 28(4):544-7. PubMed ID: 3865631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of cefotiam in patients with impaired renal function and in those undergoing hemodialysis.
    Konishi K; Ozawa Y
    Antimicrob Agents Chemother; 1984 Nov; 26(5):647-51. PubMed ID: 6097172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of cefodizime following single doses of 0.5, 1.0, 2.0, and 3.0 grams administered intravenously to healthy volunteers.
    Lenfant B; Namour F; Logeais C; Coussediere D; Rivault O; Bryskier A; Surjus A
    Antimicrob Agents Chemother; 1995 Sep; 39(9):2037-41. PubMed ID: 8540712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacokinetics of the cephalosporin antibiotic cefotiam following its intravenous administration to patients after cholecystectomy].
    Terziivanov D; Gerova Z; Vlakhov V
    Vutr Boles; 1986; 25(6):86-91. PubMed ID: 3471005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of cefotiam in normal humans.
    Daschner FD; Hemmer KA; Offermann P; Slanicka J
    Antimicrob Agents Chemother; 1982 Dec; 22(6):958-60. PubMed ID: 6297387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The human pharmacokinetics of cefotaxime and its metabolites and the role of renal tubular secretion on their elimination.
    Ings RM; Reeves DS; White LO; Bax RP; Bywater MJ; Holt HA
    J Pharmacokinet Biopharm; 1985 Apr; 13(2):121-42. PubMed ID: 4057054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma and skin blister fluid levels of cefotiam and cefmenoxime after single intramuscular application of 1 g in gonorrhea.
    Korting HC
    Chemotherapy; 1984; 30(5):277-82. PubMed ID: 6092005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and dosage adjustment of cefotiam in renal impaired patients.
    Rouan MC; Binswanger U; Bammatter F; Theobald W; Schoeller JP; Guibert J
    J Antimicrob Chemother; 1984 Jun; 13(6):611-8. PubMed ID: 6088464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crossover study of the pharmacokinetics of ceftriaxone administered intravenously or intramuscularly to healthy volunteers.
    Meyers BR; Srulevitch ES; Jacobson J; Hirschman SZ
    Antimicrob Agents Chemother; 1983 Nov; 24(5):812-4. PubMed ID: 6318657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and quantitative characterization of cefotiam excretion after intravenous administration to patients after cholecystectomy.
    Terziivanov D; Gerova Z; Vlahov V; Merdzhanov A; Damjanov D
    Eur J Clin Pharmacol; 1986; 30(4):439-44. PubMed ID: 3462003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of ceftriaxone in humans.
    Patel IH; Chen S; Parsonnet M; Hackman MR; Brooks MA; Konikoff J; Kaplan SA
    Antimicrob Agents Chemother; 1981 Nov; 20(5):634-41. PubMed ID: 6275779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose pharmacokinetics of ceftriaxone in healthy Chinese adults.
    Zhou HH; Chan YP; Arnold K; Sun M
    Antimicrob Agents Chemother; 1985 Feb; 27(2):192-6. PubMed ID: 3985603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of cefodizime administered intravenously as a single-dose (1.0 and 2.0 g) to healthy adult volunteers.
    Bryskier A; Procyk T; Tremblay D; Lenfant B; Fourtillan JB
    J Antimicrob Chemother; 1990 Nov; 26 Suppl C():65-70. PubMed ID: 2074253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of ceftriaxone after intravenous infusion and intramuscular injection.
    Scully BE; Fu KP; Neu HC
    Am J Med; 1984 Oct; 77(4C):112-6. PubMed ID: 6093511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intramuscular and intravenous pharmacokinetics of cefmenoxime, a new broad-spectrum cephalosporin, in healthy subjects.
    Granneman GR; Sennello LT; Steinberg FJ; Sonders RC
    Antimicrob Agents Chemother; 1982 Jan; 21(1):141-5. PubMed ID: 6282203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of cefotiam and cefsulodin after simultaneous administration to patients with impaired renal function.
    Lecaillon JB; Rouan MC; Binswanger U; Guibert J; Schoeller JP
    Antimicrob Agents Chemother; 1984 Sep; 26(3):368-72. PubMed ID: 6095754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pharmacokinetic behavior of cefsulodin and cefotiam alone or in combination after intravenous injection of 1 gram].
    Fourtillan JB; Bryskier A; Lefebvre MA; Ingrand I
    Pathol Biol (Paris); 1984 Jun; 32(5 Pt 2):501-5. PubMed ID: 6087247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.